Www.lifebridgehealth.org



| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |Title: |Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study (ARTEMIS) | |

| | |

| | | |

| |• are ≥ 18 years of age | |

| |• being treated with a P2Y12 receptor inhibitor at the time of enrollment | |

| |• have U.S. based health insurance coverage with prescription drug benefit | |

| |• have been fully informed and are able to provide written consent for longitudinal follow-up | |

| | | | | | | | | | | | | |PI: |Mauro Moscucci, M.D. | | | | | | | | | | | | | | | | | | | | | | | | |Phase: |IV | | | | | | | | | | | | | | | | | | | | | | | | | | |For more information: |Tonja Howell | | | | | | | | | | | | | | | | | | | | | | | | | |Telephone: |410-601-8461 | | | | | | | | | | | | | | | | | | | | | | | | | |Email: |tjhowell@ | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

-----------------------

Myocardial Infarction

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download